| Mar 18, 2014
| 4:28 AM
The decision to vaccinate your children: a parents choice or public health risk?
Last week, reality TV star Kristin Cavallari talked about about how she and her husband weren't vaccinating their children because she said, "I've read too many books about...
| Apr 15, 2014
| 3:49 AM
It just might be the only unwelcome sign of spring: Seasonal Allergies.
The sniffling, sneezing and burning eyes are back. "The pollen count is higher than normal this year, mainly because of the prolonged cold we had in the winter", says FOXCT...
| Mar 13, 2014
| 8:55 AM
Reports of Kate Middleton's severe morning sickness opened eyes about how hard pregnancy can be for some women. "I went to the emergency room because I was so sick and dehydrated after a week of not being able to eat or drink," says Megan Donofrio of...
| Nov 5, 2013
| 1:35 PM
Norwegian public television (NRK), which introduced the now-legendary continuous, live log-burning show (12 hours long, with “color commentary” on the historical and cultural importance of fire), scheduled a new program for this week in its...
| Sep 2, 2014
| 6:04 AM
COPENHAGEN (Reuters) - Danish pharmaceutical company Novo Nordisk has stopped research and development activities in inflammatory disorders to concentrate on the prevention and treatment of diabetes, its biggest business.
This follows a decision to...
| Aug 31, 2014
| 6:34 PM
CytRx Corp. is on a mission to cure cancer — or at least slow it down.
The Los Angeles biopharmaceutical company, which recently has become embroiled in a stock-promotion controversy, specializes in researching and developing drugs to treat...
| Sep 1, 2014
| 2:20 AM
BARCELONA (Reuters) - Sales forecasts for Novartis's new heart failure drug are being ramped up by analysts after strikingly good clinical trial results for a medicine doctors expect to transform treatment of the deadly disease.
Shares in the Swiss...
| Aug 24, 2014
| 2:10 PM
Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc. for $8.3 billion in cash, helping the world's leading maker of cancer drugs expand into the treatment of rare or incurable diseases.
Roche's efforts to produce successful non-...
| Aug 14, 2014
| 1:26 PM
The Securities and Exchange Commission is looking into the way that a Canadian pharmaceutical company and activist investor Bill Ackman have tried to buy Botox maker Allergan Inc. of Irvine.
Ackman's hedge fund, Pershing Square Capital Management,...
| Aug 14, 2014
| 5:43 PM
BOSTON (Reuters) - Billionaire investor William Ackman, who often says he is flattered when others follow him into a stock he likes, was joined by several prominent hedge funds that made new bets on takeover target Allergan Inc during the second quarter....
| Aug 17, 2014
For months, Advanced Grow Labs LLC — one of Connecticut's four medical marijuana growing companies — slogged through the process of competing for a state license, securing local zoning approvals, and outfitting a building to state...